Bullfrog AI Holdings, Inc. Common Stock
BFRG

$21.12 M
Marketcap
$2.69
Share price
Country
$-0.01
Change (1 day)
$8.35
Year High
$1.43
Year Low

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.

marketcap

P/E ratio for Bullfrog AI Holdings, Inc. Common Stock (BFRG)

P/E ratio as of 2023: -3.68

According to Bullfrog AI Holdings, Inc. Common Stock's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.68. At the end of 2022 the company had a P/E ratio of -14.12.

P/E ratio history for Bullfrog AI Holdings, Inc. Common Stock from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 -3.68
2022 -14.12
2021 -62.69
2020 -107.49